Published in Curr Opin Neurol on December 01, 2007
The evaluation of rapidly progressive dementia. Neurologist (2011) 1.30
Movement disorders in paraneoplastic and autoimmune disease. Curr Opin Neurol (2011) 1.28
Mechanisms underlying autoimmune synaptic encephalitis leading to disorders of memory, behavior and cognition: insights from molecular, cellular and synaptic studies. Eur J Neurosci (2010) 1.13
Small-cell lung cancer-associated autoantibodies: potential applications to cancer diagnosis, early detection, and therapy. Mol Cancer (2011) 1.10
Are onconeural antibodies a clinical phenomenology in paraneoplastic limbic encephalitis? Mediators Inflamm (2013) 0.96
Reversible paraneoplastic encephalitis in three patients with ovarian neoplasms. Acta Obstet Gynecol Scand (2012) 0.87
Immunologically mediated dementias. Curr Neurol Neurosci Rep (2009) 0.83
A case of paraneoplastic limbic encephalitis associated with small cell lung cancer. Tuberc Respir Dis (Seoul) (2012) 0.81
Marked improvement of anti-N-methyl-D-aspartate receptor encephalitis by large-dose methylprednisolone and plasmapheresis therapy combined with (18)F-fluorodeoxyglucose positron emission tomography imaging: A case report. Exp Ther Med (2014) 0.79
Cerebellar degeneration and ocular myasthenia gravis in a patient with recurring ovarian carcinoma. Neurol Sci (2009) 0.78
Anti-N-methyl-D-aspartate receptor encephalitis presenting with acute psychosis in a preteenage girl: a case report. J Med Case Rep (2012) 0.78
Rapidly progressive dementia and ataxia in an elderly man. Pract Neurol (2013) 0.76
Somatostatin receptor positron emission tomography/computed tomography (PET/CT) in the evaluation of opsoclonus-myoclonus ataxia syndrome. Indian J Nucl Med (2013) 0.75
Carcinoid Tumor-Associated Paraneoplastic Polyneuropathy that Mimics Guillain-Barre Syndrome. Noro Psikiyatr Ars (2016) 0.75
Hello from the Other Side: How Autoantibodies Circumvent the Blood-Brain Barrier in Autoimmune Encephalitis. Front Immunol (2017) 0.75
Hodgkin's lymphoma associated with paraneoplastic cerebellar degeneration in children: a case report and review of the literature. Childs Nerv Syst (2016) 0.75
Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol (2013) 11.47
Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol (2009) 9.25
Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol (2010) 7.97
Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates. Brain (2005) 6.81
Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci (2010) 6.44
Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma. Ann Neurol (2005) 5.89
Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol (2009) 5.75
A patient with encephalitis associated with NMDA receptor antibodies. Nat Clin Pract Neurol (2007) 4.63
AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol (2009) 4.49
Pediatric anti-N-methyl-D-aspartate receptor encephalitis-clinical analysis and novel findings in a series of 20 patients. J Pediatr (2012) 4.12
Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma. Acta Neuropathol (2009) 3.97
The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project. Clin Infect Dis (2012) 3.63
Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis. Ann Neurol (2014) 3.40
Neuronal autoantigens--pathogenesis, associated disorders and antibody testing. Nat Rev Neurol (2012) 3.20
Limbic encephalitis and variants: classification, diagnosis and treatment. Neurologist (2007) 3.06
Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia. Ann Neurol (2011) 2.99
N-methyl-D-aspartate receptor antibodies in herpes simplex encephalitis. Ann Neurol (2012) 2.91
Extreme delta brush: a unique EEG pattern in adults with anti-NMDA receptor encephalitis. Neurology (2012) 2.83
Herpes simplex virus-1 encephalitis can trigger anti-NMDA receptor encephalitis: case report. Neurology (2013) 2.82
Tonic seizures: a diagnostic clue of anti-LGI1 encephalitis? Neurology (2011) 2.70
EFA6A-like antibodies in paraneoplastic encephalitis associated with immature ovarian teratoma: a case report. J Neurooncol (2006) 2.67
Encephalitis and antibodies to synaptic and neuronal cell surface proteins. Neurology (2011) 2.57
Antibodies and neuronal autoimmune disorders of the CNS. J Neurol (2009) 2.40
Anti-NMDA-receptor encephalitis: a severe, multistage, treatable disorder presenting with psychosis. J Neuroimmunol (2010) 2.36
Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients. Neurology (2013) 2.32
Diagnostic value of N-methyl-D-aspartate receptor antibodies in women with new-onset epilepsy. Arch Neurol (2009) 2.25
Case records of the Massachusetts General Hospital. Case 34-2011: A 75-year-old man with memory loss and partial seizures. N Engl J Med (2011) 2.21
Frequency and characteristics of isolated psychiatric episodes in anti–N-methyl-d-aspartate receptor encephalitis. JAMA Neurol (2013) 2.12
Glycine receptor autoimmune spectrum with stiff-man syndrome phenotype. JAMA Neurol (2013) 2.10
Herpes simplex virus encephalitis is a trigger of brain autoimmunity. Ann Neurol (2014) 2.07
Autoantigen diversity in the opsoclonus-myoclonus syndrome. Ann Neurol (2003) 2.05
Cognitive deficits following anti-NMDA receptor encephalitis. J Neurol Neurosurg Psychiatry (2011) 2.01
Anti-NMDA receptor encephalitis causing prolonged nonconvulsive status epilepticus. Neurology (2010) 1.98
Update on anti-N-methyl-D-aspartate receptor encephalitis in children and adolescents. Curr Opin Pediatr (2010) 1.91
Anti-NMDA receptor encephalitis antibody binding is dependent on amino acid identity of a small region within the GluN1 amino terminal domain. J Neurosci (2012) 1.82
Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels. Ann Neurol (2012) 1.80
Acute mechanisms underlying antibody effects in anti-N-methyl-D-aspartate receptor encephalitis. Ann Neurol (2014) 1.73
Reversible brain atrophy in anti-NMDA receptor encephalitis: a long-term observational study. J Neurol (2010) 1.72
Autoimmune encephalopathies. Ann N Y Acad Sci (2014) 1.65
Anti-N-methyl-D-aspartate receptor encephalitis during pregnancy. Arch Neurol (2010) 1.59
Paraneoplastic cerebellar degeneration: Yo-expressing tumor revealed after a 5-year follow-up with FDG-PET. J Neurol Sci (2006) 1.57
The emerging link between autoimmune disorders and neuropsychiatric disease. J Neuropsychiatry Clin Neurosci (2011) 1.54
Autoimmune encephalitis in children. J Child Neurol (2012) 1.53
A novel treatment-responsive encephalitis with frequent opsoclonus and teratoma. Ann Neurol (2013) 1.50
Young girl with psychosis, cognitive failure and seizures. Tidsskr Nor Laegeforen (2012) 1.47
Serum IgG antibodies against the NR1 subunit of the NMDA receptor not detected in schizophrenia. Am J Psychiatry (2012) 1.46
Isolated hemidystonia associated with NMDA receptor antibodies. Mov Disord (2010) 1.34
Prolonged follow-up and CSF antibody titers in a patient with anti-NMDA receptor encephalitis. Neurology (2011) 1.33
In vivo effects of antibodies from patients with anti-NMDA receptor encephalitis: further evidence of synaptic glutamatergic dysfunction. Orphanet J Rare Dis (2010) 1.33
Anti-N-methyl-D-aspartate receptor encephalitis: a newly recognized inflammatory brain disease in children. Arthritis Rheum (2011) 1.32
Paraneoplastic anti-NMDAR encephalitis: long term follow-up reveals persistent serum antibodies. J Neurol (2011) 1.29
Paraneoplastic neurological syndromes. Curr Opin Neurol (2012) 1.29
Neuro-ophthalmologic manifestations of paraneoplastic syndromes. J Neuroophthalmol (2008) 1.29
Antibodies to AChR, MuSK and VGKC in a patient with myasthenia gravis and Morvan's syndrome. Nat Clin Pract Neurol (2007) 1.29
Movement disorders in paraneoplastic and autoimmune disease. Curr Opin Neurol (2011) 1.28
Paraneoplastic syndromes and autoimmune encephalitis: Five new things. Neurol Clin Pract (2012) 1.25
Treatment-responsive subacute limbic encephalitis and NMDA receptor antibodies in a man. Neurology (2008) 1.23
Clinical neuropathology practice guide 5-2012: updated guideline for the diagnosis of antineuronal antibodies. Clin Neuropathol (2012) 1.23
Anti-NMDA-Receptor Encephalitis and Other Synaptic Autoimmune Disorders. Curr Treat Options Neurol (2011) 1.22
Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg. Neurology (2014) 1.19
Fluorodeoxyglucose positron emission tomography in anti-N-methyl-D-aspartate receptor encephalitis: distinct pattern of disease. J Neurol Neurosurg Psychiatry (2012) 1.17
Psychiatric manifestations of paraneoplastic disorders. Am J Psychiatry (2010) 1.16
Diagnosis and management of paraneoplastic neurologic disorders. Curr Treat Options Oncol (2013) 1.15
Mechanisms underlying autoimmune synaptic encephalitis leading to disorders of memory, behavior and cognition: insights from molecular, cellular and synaptic studies. Eur J Neurosci (2010) 1.13
Cellular plasticity induced by anti-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor encephalitis antibodies. Ann Neurol (2015) 1.13
Autoimmune encephalitis as differential diagnosis of infectious encephalitis. Curr Opin Neurol (2014) 1.13
Anti-N-methyl-D-aspartate receptor encephalitis: characteristic behavioral and movement disorder. Arch Neurol (2010) 1.11
Persistent intrathecal antibody synthesis 15 years after recovering from anti-N-methyl-D-aspartate receptor encephalitis. JAMA Neurol (2013) 1.08
Inverse ocular bobbing in a patient with encephalitis associated with antibodies to the N-methyl-D-aspartate receptor. Arch Neurol (2008) 1.06
Afferent facilitation of corticomotor responses is increased by IgGs of patients with NMDA-receptor antibodies. J Neurol (2010) 1.06
Anti-Ma2-associated encephalitis with normal FDG-PET: a case of pseudo-Whipple's disease. Nat Clin Pract Neurol (2006) 1.04
Autoimmunity, seizures, and status epilepticus. Epilepsia (2013) 1.03
CNS autoimmunity: new findings and pending issues. Lancet Neurol (2012) 1.03
Seizures as first symptom of anti-NMDA receptor encephalitis are more common in men. Neurology (2014) 1.02
Late-onset anti-NMDA receptor encephalitis. Neurology (2013) 1.01
Antibody repertoire in paraneoplastic cerebellar degeneration and small cell lung cancer. PLoS One (2013) 1.01
An optimized immunohistochemistry technique improves NMO-IgG detection: study comparison with cell-based assays. PLoS One (2013) 1.01
Paraneoplastic neurologic syndromes. Neurol Clin (2003) 1.01
Acute psychiatric illness in a young woman: an unusual form of encephalitis. Med J Aust (2009) 0.98
Paraneoplastic recurrent multifocal encephalitis presenting with epilepsia partialis continua. J Neurooncol (2005) 0.98
Paraneoplastic syndromes of the peripheral nerves. Curr Opin Neurol (2005) 0.97
Update on paraneoplastic and autoimmune disorders of the central nervous system. Semin Neurol (2010) 0.94
Reduced N-acetylaspartate in the basal ganglia of a patient with anti-NMDA receptor encephalitis. Mov Disord (2009) 0.93
Anti-NMDA-receptor encephalitis in a 3 year old patient with chromosome 6p21.32 microdeletion including the HLA cluster. Eur J Paediatr Neurol (2010) 0.92
Authors' reply. Lancet Neurol (2013) 0.91
Update on neurological paraneoplastic syndromes. Curr Opin Oncol (2015) 0.90
Progressive multifocal leukoencephalopathy in a patient with common variable immunodeficiency and abnormal CD8+ T-cell subset distribution. Ann Allergy Asthma Immunol (2007) 0.90
Intrathecal injection of P/Q type voltage-gated calcium channel antibodies from paraneoplastic cerebellar degeneration cause ataxia in mice. J Neuroimmunol (2013) 0.90
Anti-N-methyl-D-aspartate receptor encephalitis associated with carcinosarcoma with neuroendocrine differentiation of the uterus. J Neurol (2011) 0.89
Neuro-ophthalmology and paraneoplastic syndromes. Curr Opin Neurol (2004) 0.89
Adenylate kinase 5 autoimmunity in treatment refractory limbic encephalitis. J Neuroimmunol (2007) 0.89
Anti-N-methyl D-aspartate receptor encephalitis mimics viral encephalitis. Pediatr Infect Dis J (2012) 0.89
Antibodies to N-methyl-D-aspartate and other synaptic receptors in choreoathetosis and relapsing symptoms post-herpes virus encephalitis. Mov Disord (2013) 0.89
A case of slow orthostatic tremor, responsive to intravenous immunoglobulin. Mov Disord (2011) 0.88
The MAZ protein is an autoantigen of Hodgkin's disease and paraneoplastic cerebellar dysfunction. Ann Neurol (2003) 0.87
Reversible paraneoplastic encephalitis in three patients with ovarian neoplasms. Acta Obstet Gynecol Scand (2012) 0.87
Clinical Neuropathology practice guide 4-2013: post-herpes simplex encephalitis: N-methyl-Daspartate receptor antibodies are part of the problem. Clin Neuropathol (2013) 0.86
Functional analysis of CD8+ T cell responses to the onconeural self protein cdr2 in patients with paraneoplastic cerebellar degeneration. J Neuroimmunol (2007) 0.86
ZIC antibodies in paraneoplastic cerebellar degeneration and small cell lung cancer. J Neuroimmunol (2008) 0.86
Paraneoplastic sensory neuronopathy and spontaneous regression of small cell lung cancer. Can J Neurol Sci (2003) 0.84